Normal and prostate cancer cells display distinct molecular profiles of α-tubulin posttranslational modifications

Prostate

Volumn 66, Issue 9, 2006, Pages 954-965

  Souček, Karel ^a   Kamaid, Andrés ^a,d   Phung, Anh D ^a   Kubala, Lukáš ^a   Bulinski, J Chloë ^c   Harper, Richart W ^a   Eiserich, Jason P ^a,b,e,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

^e Division of Nephrology   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acetylation; Detyrosination; HDAC6; Microtubules; Polyglutamylation; Prostate cancer; SIRT2; Tubulin tyrosine ligase

Indexed keywords

ALPHA TUBULIN; BIOLOGICAL MARKER; LIGASE; TUBULIN TYROSINE LIGASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL IMMORTALIZATION; CELL STRAIN LNCAP; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; MICROTUBULE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ACETYLATION; PROTEIN DETYROSINATION; PROTEIN EXPRESSION; PROTEIN POLYGLUTAMYLATION; PROTEIN PROCESSING;

ACETYLATION; ANDROGENS; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; DISEASE PROGRESSION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITHELIUM; HUMANS; MALE; MICROSCOPY, FLUORESCENCE; PEPTIDE SYNTHASES; POLYGLUTAMIC ACID; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, ANDROGEN; TUBULIN; TYROSINE;

EID: 33744901133     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20416     Document Type: Article

References (49)

1. Stotts RC. Cancers of the prostate, penis, and testicles: Epidemiology, prevention, and treatment. Nurs Clin North Am 2004;39(2):327-340.
2. Musch A. Microtubule organization and function in epithelial cells. Traffic 2004;5(1):1-9.
3. McKean PG, Vaughan S, Gull K. The extended tubulin superfamily. J Cell Sci 2001;114(Pt 15):2723-2733.
4. Sangrajrang S, Denoulet P, Laing NM, Tatoud R, Millot G, Calvo F, Tew KD, Fellous A. Association of estramustine resistance in human prostatic carcinoma cells with modified patterns of tubulin expression. Biochem Pharmacol 1998;55(3):325-331.
5. Burkhart CA, Kavallaris M, Band Horwitz S. The role of beta-tubulin isotypes in resistance to antimitotic drugs. Biochim Biophys Acta 2001;1471(2):O1-O9.
6. Luduena RF. Are tubulin isotypes functionally significant. Mol Biol Cell 1993;4(5):445-457.
7. Westermann S, Weber K. Post-translational modifications regulate microtubule function. Nat Rev Mol Cell Biol 2003;4(12):938-947.
8. Argarana CE, Barra HS, Caputto R. Release of [14C]tyrosine from tubulinyl-[14C]tyrosine by brain extract. Separation of a carboxypeptidase from tubulin-tyrosine ligase. Mol Cell Biochem 1978;19(1):17-21.
9. Erck C, Frank R, Wehland J. Tubulin-tyrosine ligase, a long-lasting enigma. Neurochem Res 2000;25(1):5-10.
10. Webster DR, Modesti NM, Bulinski JC. Regulation of cytoplasmic tubulin carboxypeptidase activity during neural and muscle differentiation: Characterization using a microtubule-based assay. Biochemistry 1992;31(25):5849-5856.
11. Geuens G, Gundersen GG, Nuydens R, Cornelissen F, Bulinski JC, DeBrabander M. Ultrastructural colocalization of tyrosinated and detyrosinated alpha-tubulin in interphase and mitotic cells. J Cell Biol 1986;103(5):1883- 1893.
12. Eiserich JP, Estevez AG, Bamberg TV, Ye YZ, Chumley PH, Beckman JS, Freeman BA. Microtubule dysfunction by posttranslational nitrotyrosination of alpha-tubulin: A nitric oxide-dependent mechanism of cellular injury. Proc Natl Acad Sci USA 1999;96(11):6365-6370.
13. Chang W, Webster DR, Salam AA, Gruber D, Prasad A, Eiserich JP, Bulinski JC. Alteration of the C-terminal amino acid of tubulin specifically inhibits myogenic differentiation. J Biol Chem 2002;277(34):30690-30698.
14. Finkelstein E, Chang W, Chao PHG, Gruber D, Minden A, Hung CT, Bulinski JC. Roles of microtubules, cell polarity and adhesion in electric-field-mediated motility of 3T3 fibroblasts. J Cell Sci 2004;117(8):1533-1545.
15. Kato C, Miyazaki K, Nakagawa A, Ohira M, Nakamura Y, Ozaki T, Imai T, Nakagawara A. Low expression of human tubulin tyrosine ligase and suppressed tubulin tyrosination/detyrosination cycle are associated with impaired neuronal differentiation in neuroblastomas with poor prognosis. Int J Cancer 2004;112(3):365-375.
16. Mialhe A, Lafanechere L, Treilleux I, Peloux N, Dumontet C, Bremond A, Panh MH, Payan R, Wehland J, Margolis RL, Job D. Tubulin detyrosination is a frequent occurrence in breast cancers of poor prognosis. Cancer Res 2001;61(13):5024-5027.
17. Lafanechere L, Courtay-Cahen C, Kawakami T, Jacrot M, Rudiger M, Wehland J, Job D, Margolis RL. Suppression of tubulin tyrosine ligase during tumor growth. J Cell Sci 1998;111(Pt 2):171-181.
18. Lafanechere L, Job D. The third tubulin pool. Neurochem Res 2000;25(1):11-18.
19. Boucher D, Larcher JC, Gros F, Denoulet P. Polyglutamylation of tubulin as a progressive regulator of in vitro interactions between the microtubule-associated protein Tau and tubulin. Biochemistry 1994;33(41):12471-12477.
20. Przyborski SA, Cambray-Deakin MA. Profile of glutamylated tubulin expression during cerebellar granule cell development in vitro. Brain Res Dev Brain Res 1997;100(1):133-138.
21. Bobinnec Y, Moudjou M, Fouquet JP, Desbruyeres E, Edde B, Bornens M. Glutamylation of centriole and cytoplasmic tubulin in proliferating non-ncuronal cells. Cell Motil Cytoskeleton 1998;39(3):223-232.
22. Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A, Yoshida M, Wang XF, Yao TP. HDAC6 is a microtubule-associated deacetylase. Nature 2002;417(6887):455-458.
23. North BJ, Marshall BL, Borra MT, Denu JM, Verdin E. The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell 2003;11(2):437-444.
24. Palazzo A, Ackerman B, Gundersen GG. Cell biology: Tubulin acetylation and cell motility. Nature 2003;421(6920):230.
25. Maruta H, Greer K, Rosenbaum JL. The acetylation of alpha-tubulin and its relationship to the assembly and disassembly of microtubules. J Cell Biol 1986;103(2):571-579.
26. Shi XB, Ma AH, Tepper CG, Xia L, Gregg JP, Candour-Edwards R, Mack PC, Kung HJ, deVere White RW. Molecular alterations associated with LNCaP cell progression to androgen independence. Prostate 2004;60(3):257-271.
27. Tepper CG, Boucher DL, Ryan PE, Ma AH, Xia L, Lee LF, Pretlow TG, Kung HJ. Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line. Cancer Res 2002;62(22):6606-6614.
28. Gundersen GG, Kalnoski MH, Bulinski JC. Distinct populations of microtubules: Tyrosinated and nontyrosinated alpha tubulin are distributed differently in vivo. Cell 1984;38(3):779-789.
29. Kann ML, Prigent Y, Levilliers N, Bre MH, Fouquet JP. Expression of glycylnted tubulin during the differentiation of spermatozoa in mammals. Cell Motil Cytoskeleton 1998;41(4):341-352.
30. Schulze E, Asai DJ, Bulinski JC, Kirschner M. Posttranslational modification and microtubule stability. J Cell Biol 1987;105(5):2167-2177.
31. Kalisz HM, Erck C, Plessmann U, Wehland J. Incorporation of nitrotyrosine into alpha-tubulin by recombinant mammalian tubulin-tyrosine ligase. Biochim Biophys Acta 2000;1481(1):131-138.
32. Li LC, Carroll PR, Dahiya R. Epigenetic changes in prostate cancer: Implication for diagnosis and treatment. J Natl Cancer Inst 2005;97(2):103-115.
33. Li LC, Okino ST, Dahiya R. DNA methylation in prostate cancer. Biochim Biophys Acta 2004;1704(2):87-102.
34. Janke C, Rogowski K, Wloga D, Regnard C, Kajava AV, Strub JM, Temurak N, van Dijk J, Boucher D, van Dorsselaer A, Suryavanshi S, Gaertig J, Edde B. Tubulin polyglutamylase enzymes are members of the TTL domain protein family. Science 2005;308(5729):1758-1762.
35. Yeh IT, Luduena RF. The betaII isotype of tubulin is present in the cell nuclei of a variety of cancers. Cell Motil Cytoskeleton 2004;57(2):96-106.
36. Yeh TS, Hsieh RH, Shen SC, Wang SH, Tseng MJ, Shih CM, Lin JJ. Nuclear betaII-tubulin associates with the activated notch receptor to modulate notch signaling. Cancer Res 2004;64(22):8334-8340.
37. Gurland C, Gundersen GG. Stable, detyrosinated microtubules function to localize vimentin intermediate filaments in fibroblasts. J Cell Biol 1995;131(5):1275-1290.
38. Kreitzer G, Liao G, Gundersen GG. Detyrosination of tubulin regulates the interaction of intermediate filaments with microtubules in vivo via a kinesin-dependent mechanism. Mol Biol Cell 1999;10(4):1105-1118.
39. Fu M, Wang C, Zhang X, Pestell RG. Acetylation of nuclear receptors in cellular growth and apoptosis. Biochem Pharmacol 2004;68(6):1199-1208.
40. Fu M, Rao M, Wang C, Sakamaki T, Wang J, Di Vizio D, Zhang X, Albanese C, Balk S, Chang C, Fan S, Rosen E, Palvimo JJ, Janne OA, Muratoglu S, Avantaggiati ML, Pestell RG. Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth. Mol Cell Biol 2003;23(23):8563-8575.
41. Li J, Wang E, Rinaldo F, Datta K. Upregulation of VEGF-C by androgen depletion: The involvement of IGF-IR-FOXO pathway. Oncogene 2005.
42. Haggarty SJ, Koeller KM, Wong JC, Grozinger CM, Schreiber SL. Domain-selective small-molecule inhibitor of histone deacetylase6(HDAC6)- mediated tubulin doacetylation. Proc Natl Acad Sci USA 2003;100(8):4389-4394.
43. Zhou J, Scholes J, Hsieh JT. Signal transduction targets in androgen-independent prostate cancer. Cancer Metastasis Rev 2001;20(3-4):351- 362.
44. Voelter-Mahlknecht S, Mahlknecht U. Cloning and structural characterization of the human histone deacetylase 6 gene. Int J Mol Med 2003;12(1):87-93.
45. Voelter-Mahlknecht S, Ho AD, Mahlknecht U. FISH-mapping and genomic organization of the NAD-dependent histone deacetylase gene, Sirtuin 2 (Sirt2). Int J Oncol 2005;27(5):1187-1196.
46. Pakneshan P, Szyf M, Rabbani SA. Hypomethylation of urokinase (uPA) promoter in breast and prostate cancer: Prognostic and therapeutic implications. Curr Cancer Drug Targets 2005;5(7):471-488.
47. Tokizane T, Shiina H, Igawa M, Enokida H, Urakami S, Kawakami T, Ogishima T, Okino ST, Li LC, Tanaka Y, Nonomura N, Okuyama A, Dahiya R. Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin Cancer Res 2005;11(16):5793-5801.
48. Ogishima T, Shiina H, Breault JE, Tabatabai L, Bassett WW, Enokida H, Li LC, Kawakami T, Urakami S, Ribeiro-Filho LA, Terashima M, Fujime M, Igawa M, Dahiya R. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer. Clin Cancer Res 2005;11(3):1028-1036.
49. Waltregny D, North B, Van Mellaert F, de Leval J, Verdin E, Castronovo V. Screening of histone deacetylases (HDAC) expression in human prostate cancer reveals distinct class 1 HDAC profiles between epithelial and stromal cells. Eur J Histochem 2004;48(3):273-290.